Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects

NCT01012258 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

BIOLOGICAL: Cetuximab + concomitant boost radiotherapy

Sponsor

Merck KGaA, Darmstadt, Germany